Combined dysmetabolism and risk factors of elevated serum alanine aminotransferase

( views:182, downloads:0 )
LIU An-nan(Department of Special Medical,Beijing Hospital,Beijing 100730,China)
ZHU Ling()
ZHAO Yan-yan()
SONG Yue-hua()
GAO Jian-ping()
Journal Title:
Volume 04, Issue 05, 2010
Key Word:
Alanine transaminase;Lipid metabolism;Fatty liver

Abstract: Objective To investigate the prevalence of elevated serum alanine aminotransferase ( ALT) and ALT-related dysmetabolism and risk factors. Methods A total of 12 789 adult participated,with no hepatitis B virus infection or alcohol over-intake, received health check-up, including blood pressure measurement, blood glucose and lipid profile test, liver function evaluation and ultrasonography. The subjects were then assigned into two groups according to the serum level of ALT. Metabolic composition was compared between the two groups. Results The prevalence of elevated ALT activity was 8.69%. The waist circumstance,body mass index (BMI) ,systolic blood pressure (SBP) ,diastolic blood pressure (DBP) ,total cholesterol (TC) ,triglyceride (TG) , low-density lipoprotein cholesterol (LDL-C) , urine acid (UA) , fasting blood glucose (FBG) ,HbAlc,total bilirubin (TBIL) ,-y-glutamyltransferase (GGT) ,alkaline phos-phatase ( ALP) of the elevated ALT group were significantly higher than those of the normal ALT group. However,age and high-density lipoprotein cholesterol ( HDL-C) in the elevated ALT group were lower than those in the normal ALT group ( P < 0. 05 ) . The occurrence of overweight, obesity, hyperlipidemia, impaired fasting glucose,diabetes, increased DBP, hyperuricacidemia and fatty liver in the elevated serum ALT group was significantly more than that in the normal ALT group ( P < 0. 05 ) . Multiple logistic regression analysis demonstrated that fatty liver, DBP, BMI.TC, HbAlc were risk factors of elevated serum ALT. Conclusion Non-alcoholic fatty liver disease, lipid metabolic disorders and obesity may be the main risk factors of elevated ALT.

  • [1]Poursbems A,Malekzadeh B,Monawari A,et al.Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.J Gastreenterol Hepatol,2005,20:229-233.
  • [2]Ioannou GN,Weiss NS,Boyko FJ,et al.Contribution of metabolic[actors to alanine aminotransferase activity in persons with other causes of liver disease.Gastroenterology,2005,128:627-635.
  • [3]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华肝脏病杂志,2006,14:161-163.
  • [4]中国成人血脂异常防治指南制订联合委员.中国成人血脂异常防治指南.中华心血管病杂志,2007,35:390-419.
  • [5]Hanley A J,Williams K,Festa A,et al.Elevations in markers of liver injury and risk of type 2 diabetes:the insulin resistance atberosclerosis study.Diabetes,2004,53:2623-2632.
  • [6]Pendino GM,Mariano A,Suraco P,et al.Prevalence and etiology of altered liver tests:A population-based survey in a Mediterranean town.Hepatology,2005,41:1151-1159.
  • [7]Kotronen A,Westerbecka J,Bergholm R,et al.Liver fat in the metabolic syndrome.J Clin Endocrinol Metab,2007,92:3490-3497.
  • [8]蔡晓波,范建高,朱军,等.成人不明原因丙氨酸转氨酶升高危险因素分析.诊断学理论与实践,2007,6:331-334.
  • [9]王宁双,张云,柳海滨,等.非酒精性血清丙氨酸转氨酶升高与代谢参数的相关性分析.中华全科医师杂志,2008,7:748-750.
  • [10]Oh SY,Cho YK,Kang MS,et al.The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.Metabolism,2006,55:1604-1609.
  • [11]Kim J,Jo I.Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.Eur J Clin Nutr,2010,64:169-175.
  • [12]Lee JK,Shim JH,Lee HC,et al.Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.Hepatology,2010,51:1577-1583.
  • [13]Mardi T,Toker S,Melamed S,et al.Increased erythropoiesis and subclinical infammation as part of the metabolic syndrome.Diabetes Res Clin Pract,2005,69:249-255.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615